Endovascular Treatment of Brain Arteriovenous Malformations After New Liquid Embolic Agents: A Single-Center 7-Year Experience With Safety Outcomes
PHIL and Squid demonstrated complication and angiographic cure rates comparable with Onyx. However, curative embolization of brain AVMs resulted in only moderate angiographic occlusion. Larger multicenter studies with standardized operator protocols, cost-effectiveness assessments, and extended follow-up are warranted to validate these findings.
Authors
- Vanessa Chalumeau (ORCID: https://orcid.org/0000-0002-7753-7186)
- Cristian Mihalea (ORCID: https://orcid.org/0000-0002-8260-8284)
- Natália Vasconcellos de Oliveira Souza (ORCID: https://orcid.org/0000-0002-1032-5787)
- Laurent Spelle (ORCID: https://orcid.org/0000-0002-6748-8528)
- Sébastien Soize (ORCID: https://orcid.org/0000-0002-6893-661X)
- Léon Ikka (ORCID: https://orcid.org/0000-0002-6739-3692)
- Jonathan Cortese (ORCID: https://orcid.org/0000-0002-1616-9113)
- Fernanda Rodriguez‐Erazú (ORCID: https://orcid.org/0009-0000-1568-0043)
- Jildaz Caroff (ORCID: https://orcid.org/0000-0002-0029-1835)
- Maria JoséFemenias Vieira (ORCID: https://orcid.org/0000-0003-1516-6356)
Institutions
- Inserm (FR)
- Université Paris-Saclay (FR)
- Jacksonville College (US)
- Centre Hospitalier Universitaire de Reims (FR)
- Mayo Clinic in Florida (US)
- Bicêtre Hospital (FR)
- Université de Reims Champagne-Ardenne (FR)
Publication Details
- Journal
- Neurosurgery
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1227/neu.0000000000003691
- Primary Topic
- Vascular Malformations Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00